Jump Financial LLC Acquires 25,200 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC)

Jump Financial LLC grew its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 31.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 105,200 shares of the company's stock after purchasing an additional 25,200 shares during the quarter. Jump Financial LLC owned 0.05% of Alignment Healthcare worth $1,184,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Barclays PLC grew its stake in shares of Alignment Healthcare by 3.7% during the fourth quarter. Barclays PLC now owns 200,564 shares of the company's stock valued at $2,256,000 after acquiring an additional 7,118 shares in the last quarter. TME Financial Inc. acquired a new stake in Alignment Healthcare during the 4th quarter valued at approximately $175,000. Next Century Growth Investors LLC purchased a new stake in Alignment Healthcare during the 4th quarter worth approximately $11,453,000. Raymond James Financial Inc. acquired a new position in shares of Alignment Healthcare in the 4th quarter valued at approximately $1,769,000. Finally, Renaissance Technologies LLC raised its position in shares of Alignment Healthcare by 15.3% in the 4th quarter. Renaissance Technologies LLC now owns 1,769,500 shares of the company's stock valued at $19,907,000 after purchasing an additional 235,000 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Wall Street Analysts Forecast Growth

ALHC has been the topic of a number of research analyst reports. Stephens reaffirmed an "overweight" rating and set a $17.00 target price on shares of Alignment Healthcare in a report on Monday, February 24th. Barclays raised their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a research note on Friday, February 28th. Robert W. Baird boosted their target price on shares of Alignment Healthcare from $17.00 to $22.00 and gave the company an "outperform" rating in a research note on Tuesday, April 15th. Stifel Nicolaus raised their price target on shares of Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research report on Tuesday, April 8th. Finally, Bank of America boosted their price objective on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a research report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $16.61.

Alignment Healthcare Stock Down 2.9 %

NASDAQ:ALHC traded down $0.52 during trading hours on Friday, hitting $17.52. 3,180,864 shares of the stock traded hands, compared to its average volume of 1,714,107. The firm has a 50 day moving average price of $16.94 and a 200 day moving average price of $14.08. The firm has a market cap of $3.36 billion, a price-to-earnings ratio of -22.75 and a beta of 1.32. Alignment Healthcare, Inc. has a fifty-two week low of $5.02 and a fifty-two week high of $21.06. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Insider Activity at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 230,000 shares of the firm's stock in a transaction on Monday, April 14th. The shares were sold at an average price of $19.10, for a total value of $4,393,000.00. Following the sale, the president now owns 2,132,899 shares in the company, valued at approximately $40,738,370.90. This trade represents a 9.73 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO John E. Kao sold 554,713 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.53, for a total transaction of $8,614,692.89. Following the transaction, the chief executive officer now owns 4,733,664 shares in the company, valued at approximately $73,513,801.92. The trade was a 10.49 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 2,156,855 shares of company stock valued at $34,744,307. Insiders own 6.60% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.